| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
225,005 | 253,213 | 199,736 | 196,014 | 95,070 |
| Cost of Revenue
|
-20,891 | -21,926 | -20,994 | -20,149 | -18,316 |
|
Gross Profit
|
204,114 | 231,287 | 178,742 | 175,865 | 76,754 |
| Selling, General and Administrative Expenses
|
-35,199 | -34,864 | -34,909 | -36,202 | -34,005 |
| Other Income/Expense, Operating
|
-2,415 | -1,120 | -577 | -1,053 | -1,257 |
|
Operating Income/Expenses
|
-37,614 | -35,984 | -35,486 | -37,255 | -35,262 |
|
Total Operating Profit/Loss
|
166,500 | 195,303 | 143,256 | 138,610 | 41,492 |
| Total Net Finance Income/Expense
|
5,501 | 5,515 | 4,379 | 1,754 | 601 |
| Net Investment Income
|
-159,083 | -225,382 | -272,459 | -69,935 | -6,952 |
|
Non-Operating Income/Expenses, Total
|
-153,582 | -219,867 | -268,080 | -68,181 | -6,351 |
|
Pretax Income
|
12,918 | -24,564 | -124,824 | 70,429 | 35,141 |
|
Provision for Income Tax
|
-21,711 | -25,416 | -21,856 | -21,468 | -22,873 |
|
Net Income from Continuing Operations
|
-8,793 | -49,980 | -146,680 | 48,961 | 12,268 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-8,793 | -49,980 | -146,680 | 48,961 | 12,268 |
|
Net Income after Non-Controlling/Minority Interests
|
-8,793 | -49,980 | -146,680 | 48,961 | 12,268 |
|
Net Income Available to Common Stockholders
|
-8,793 | -49,980 | -146,680 | 48,961 | 12,268 |
|
Diluted Net Income Available to Common Stockholders
|
-8,793 | -49,980 | -146,680 | 48,961 | 12,268 |
|
Common Dividend per Share
|
0.00 | 0.70 | 0.70 | 0.70 | 0.70 |
|
Special Dividend per Share
|
0.00 | 0.60 | 0.40 | 0.60 | 0.30 |
| Basic EPS
|
-0.26 | -1.47 | -4.32 | 1.44 | 0.36 |
| Diluted EPS
|
-0.26 | -1.47 | -4.32 | 1.44 | 0.36 |
|
Basic Weighted Average Shares Outstanding
|
33,968 | 33,968 | 33,968 | 33,968 | 33,968 |
|
Diluted Weighted Average Shares Outstanding
|
33,968 | 33,968 | 33,968 | 33,968 | 33,968 |
|
Reported Normalized Basic EPS
|
4.95 | 6.27 | 3.84 | 3.67 | 0.73 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
7,417 | -30,079 | -129,203 | 68,675 | 34,540 |
|
EBITDA
|
7,417 | -26,949 | -125,660 | 72,217 | 38,262 |
|
Normalized EBITDA
|
7,417 | -26,410 | -128,427 | 72,368 | 39,298 |
|
Normalized Income
|
167,896 | 212,866 | 130,234 | 124,534 | 24,694 |
|
Total Unusual Items
|
0 | 539 | -2,767 | 151 | 1,036 |
12/31/2022 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade